Banco de Sabadell’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-76,792
| Closed | -$2.23M | – | 60 |
|
|
2024
Q3 | $2.23M | Buy |
76,792
+8,023
| +12% | +$234K | 1.67% | 30 |
|
|
2024
Q2 | $1.93M | Sell |
68,769
-1,999
| -3% | -$55K | 1.41% | 36 |
|
|
2024
Q1 | $1.97M | Sell |
70,768
-1,092
| -2% | -$30.3K | 1.46% | 36 |
|
|
2023
Q4 | $2.06M | Buy |
71,860
+34,845
| +94% | +$1.05M | 1.57% | 36 |
|
|
2023
Q3 | $1.22M | Sell |
37,015
-3,784
| -9% | -$134K | 1.06% | 43 |
|
|
2023
Q2 | $1.5M | Sell |
40,799
-1,386
| -3% | -$53.9K | 1.21% | 41 |
|
|
2023
Q1 | $1.72M | Sell |
42,185
-2,560
| -6% | -$111K | 1.43% | 38 |
|
|
2022
Q4 | $2.3M | Sell |
44,745
-5,016
| -10% | -$240K | 1.93% | 19 |
|
|
2022
Q3 | $2.18M | Buy |
49,761
+628
| +1% | +$30.5K | 1.8% | 19 |
|
|
2022
Q2 | $2.58M | Sell |
49,133
-511
| -1% | -$26K | 2.16% | 12 |
|
|
2022
Q1 | $2.57M | Buy |
49,644
+2,286
| +5% | +$119K | 1.49% | 24 |
|
|
2021
Q4 | $2.8M | Buy |
47,358
+6,793
| +17% | +$337K | 1.57% | 21 |
|
|
2021
Q3 | $1.75M | Sell |
40,565
-3,767
| -8% | -$167K | 1.17% | 41 |
|
|
2021
Q2 | $1.73M | Sell |
44,332
-299,850
| -87% | -$11.7M | 1.15% | 39 |
|
|
2021
Q1 | $12.5M | Buy |
344,182
+264,713
| +333% | +$9.4M | 1.29% | 20 |
|
|
2020
Q4 | $2.93M | Sell |
79,469
-178,965
| -69% | -$6.56M | 0.31% | 88 |
|
|
2020
Q3 | $8.94M | Sell |
258,434
-62,686
| -20% | -$2.2M | 1.01% | 22 |
|
|
2020
Q2 | $9.96M | Buy |
321,120
+19,922
| +7% | +$677K | 1.29% | 19 |
|
|
2020
Q1 | $9.27M | Sell |
301,198
-12,671
| -4% | -$432K | 1.46% | 13 |
|
|
2019
Q4 | $11.6M | Sell |
313,869
-19,300
| -6% | -$687K | 1.54% | 13 |
|
|
2019
Q3 | $11.4M | Sell |
333,169
-11,533
| -3% | -$419K | 1.59% | 13 |
|
|
2019
Q2 | $14.2M | Buy |
344,702
+298,930
| +653% | +$11.9M | 1.64% | 6 |
|
|
2019
Q1 | $1.84M | Sell |
45,772
-367,096
| -89% | -$14.7M | 0.24% | 109 |
|
|
2018
Q4 | $16.9M | Buy |
412,868
+51,394
| +14% | +$2.13M | 2.07% | 3 |
|
|
2018
Q3 | $15.1M | Buy |
361,474
+70,776
| +24% | +$2.72M | 1.65% | 7 |
|
|
2018
Q2 | $10M | Sell |
290,698
-68,768
| -19% | -$2.35M | 1.28% | 11 |
|
|
2018
Q1 | $12M | Buy |
359,466
+18,947
| +6% | +$651K | 1.44% | 9 |
|
|
2017
Q4 | $11.7M | Buy |
+340,519
| New | +$11.6M | 1.5% | 11 |
|
Other funds holding PFE
Banco de Sabadell's PFE Position: Q4 2024 in Review
Banco de Sabadell sold out of Pfizer (PFE) in Q4 2024, closing a stake of 76,792 shares — an estimated $2.23M sold.
Banco de Sabadell first reported a position in PFE in Q4 2017 and held it in 28 quarters. The position peaked at $16.9M in Q4 2018. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Banco de Sabadell reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Banco de Sabadell sold 76,792 Pfizer shares in Q4 2024, an estimated $2.23M.
- Banco de Sabadell first reported a position in Pfizer in Q4 2017 and held it in 28 quarters.
- Banco de Sabadell's Pfizer position peaked at $16.9M in Q4 2018.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Banco de Sabadell's 13F filing for Q4 2024, filed 11 Feb 2025.